image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 1.02
-4.67 %
$ 1.76 M
Market Cap
-0.2
P/E
1. INTRINSIC VALUE

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.[ Read More ]

The intrinsic value of one BACK stock under the base case scenario is HIDDEN Compared to the current market price of 1.02 USD, IMAC Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart BACK

image
FINANCIALS
5.2 M REVENUE
-67.89%
-6.38 M OPERATING INCOME
35.26%
-9.42 M NET INCOME
48.57%
-2.79 M OPERATING CASH FLOW
72.90%
-1.78 M INVESTING CASH FLOW
-582.85%
4.02 M FINANCING CASH FLOW
-4.17%
0 REVENUE
100.00%
-409 K OPERATING INCOME
-25.54%
-407 K NET INCOME
72.07%
-202 K OPERATING CASH FLOW
-121.11%
0 INVESTING CASH FLOW
0.00%
-1.72 K FINANCING CASH FLOW
99.35%
Balance Sheet Decomposition IMAC Holdings, Inc.
image
Current Assets 1.14 M
Cash & Short-Term Investments 222 K
Receivables 731 K
Other Current Assets 192 K
Non-Current Assets 762 K
Long-Term Investments 0
PP&E 762 K
Other Non-Current Assets 0
Current Liabilities 1.9 M
Accounts Payable 584 K
Short-Term Debt 0
Other Current Liabilities 1.31 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall IMAC Holdings, Inc.
image
Revenue 5.2 M
Cost Of Revenue 1.35 M
Gross Profit 3.85 M
Operating Expenses 5.03 M
Operating Income -6.38 M
Other Expenses 3.04 M
Net Income -9.42 M
RATIOS
74.05% GROSS MARGIN
74.05%
-122.68% OPERATING MARGIN
-122.68%
0.00% NET MARGIN
0.00%
0.00% ROE
0.00%
0.00% ROA
0.00%
847.08% ROIC
847.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis IMAC Holdings, Inc.
image
Net Income -9.42 M
Depreciation & Amortization 404 K
Capital Expenditures 0
Stock-Based Compensation 83 K
Change in Working Capital 810 K
Others 5.08 M
Free Cash Flow -2.79 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets IMAC Holdings, Inc.
image
BACK has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership IMAC Holdings, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 years ago
Apr 07, 2021
Sell 640 K USD
Wallis Matthew C
Chief Operating Officer
- 400000
1.6 USD
3 years ago
Mar 25, 2021
Bought 1.23 K USD
Pruitt Michael D
Director
+ 750
1.64 USD
4 years ago
Sep 10, 2020
Bought 3.14 K USD
Ervin Jeffrey S
Chief Executive Officer
+ 4000
0.785 USD
4 years ago
Sep 10, 2020
Bought 3.14 K USD
Ervin Jeffrey S
Chief Executive Officer
+ 4000
0.785 USD
4 years ago
Sep 10, 2020
Bought 766 USD
Ervin Jeffrey S
Chief Executive Officer
+ 1000
0.766 USD
4 years ago
Sep 10, 2020
Bought 766 USD
Ervin Jeffrey S
Chief Executive Officer
+ 1000
0.766 USD
4 years ago
Apr 03, 2020
Bought 1.45 K USD
Ervin Jeffrey S
Chief Executive Officer
+ 1000
1.45 USD
4 years ago
Apr 03, 2020
Bought 1.45 K USD
Ervin Jeffrey S
Chief Executive Officer
+ 1000
1.45 USD
5 years ago
Nov 19, 2019
Bought 226 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.26 USD
5 years ago
Nov 19, 2019
Bought 226 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.26 USD
5 years ago
Nov 19, 2019
Bought 223 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.23 USD
5 years ago
Nov 19, 2019
Bought 223 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.23 USD
5 years ago
Nov 19, 2019
Bought 633 USD
Ervin Jeffrey S
Chief Executive Officer
+ 300
2.11 USD
5 years ago
Nov 19, 2019
Bought 633 USD
Ervin Jeffrey S
Chief Executive Officer
+ 300
2.11 USD
5 years ago
Nov 19, 2019
Bought 212 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.12 USD
5 years ago
Nov 19, 2019
Bought 212 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.12 USD
5 years ago
Nov 18, 2019
Bought 210 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.1 USD
5 years ago
Nov 18, 2019
Bought 210 USD
Ervin Jeffrey S
Chief Executive Officer
+ 100
2.1 USD
5 years ago
Nov 18, 2019
Bought 618 USD
Ervin Jeffrey S
Chief Executive Officer
+ 300
2.06 USD
5 years ago
Nov 18, 2019
Bought 618 USD
Ervin Jeffrey S
Chief Executive Officer
+ 300
2.06 USD
5 years ago
Nov 18, 2019
Bought 422 USD
Ervin Jeffrey S
Chief Executive Officer
+ 200
2.11 USD
5 years ago
Nov 18, 2019
Bought 422 USD
Ervin Jeffrey S
Chief Executive Officer
+ 200
2.11 USD
5 years ago
Feb 15, 2019
Bought 97.6 K USD
Weiland Dean
Director
+ 19512
5 USD
5 years ago
Feb 15, 2019
Bought 100 K USD
Weiland Dean
Director
+ 19512
5.125 USD
5 years ago
Feb 15, 2019
Bought 50 K USD
Weiland Dean
Director
+ 9756
5.125 USD
5 years ago
Feb 15, 2019
Bought 50 K USD
Weiland Dean
Director
+ 9756
5.125 USD
5 years ago
Feb 15, 2019
Bought 21.5 K USD
HAMPTON GEORGE P
Director
+ 4292
5 USD
5 years ago
Feb 15, 2019
Bought 22 K USD
HAMPTON GEORGE P
Director
+ 4292
5.125 USD
5 years ago
Feb 15, 2019
Bought 11 K USD
HAMPTON GEORGE P
Director
+ 2146
5.125 USD
5 years ago
Feb 15, 2019
Bought 11 K USD
HAMPTON GEORGE P
Director
+ 2146
5.125 USD
7. News
IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). This exception extends the deadline for the Company to file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”) until February 17, 2025. globenewswire.com - 2 days ago
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new precision oncology assay for breast cancer treatment decision making utilizing the Reverse Phase Protein Array (RPPA) technology through its newly established subsidiary, Ignite Proteomics LLC (“Ignite Proteomics”). This launch follows IMAC Holdings' strategic acquisition of key assets from Theralink Technologies, Inc., and is underscored by a landmark clinical case study “ Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer”, demonstrating the power of RPPA technology in precision oncology published in npj Precision Oncology, an international, peer-reviewed journal focused on precision oncology. globenewswire.com - 1 month ago
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the “SEC”) on August 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC. globenewswire.com - 2 months ago
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors Golden, CO, July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of Dr. Peter Beitsch and Dr. Matthew Schwartz to its Board of Directors, effective June 26, 2024. This strategic move underscores the Company's commitment to advancing its position in the field of proteomics and driving innovation in precision medicine. globenewswire.com - 4 months ago
IMAC Holdings Announces Leadership Succession Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the board of directors and executive team. globenewswire.com - 5 months ago
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ: BACK) (“BACK”) and Theralink Technologies, Inc. (“Theralink”), BACK acquired the assets of Theralink, other than certain excluded assets, in settlement of the default by Theralink of certain outstanding debt and BACK's agreement to issue certain shares of preferred stock of BACK to Theralink and/or certain holders of debt of Theralink, as applicable, in the future following the completion of a third party valuation of Theralink's business. globenewswire.com - 6 months ago
IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market and that it is in compliance with all applicable listing standards. globenewswire.com - 1 year ago
IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the Company's Certificate of Incorporation in order to effect the Reverse Split. The Reverse Split will be effective after the market closes on September 7, 2023. Beginning with the opening of trading on September 8, 2023, the Company's common stock will continue to trade on The Nasdaq Capital Market under the symbol “BACK,” but will trade on a split-adjusted basis under a new CUSIP number, 44967K302. globenewswire.com - 1 year ago
If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names Penny stocks are generally defined as securities that trade for less than $5 a share. These stocks can be volatile and unpredictable, leading many investors to avoid them. investorplace.com - 1 year ago
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company” ), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities purchase agreement with several institutional and accredited investors, including existing significant investors of Theralink Technologies, Inc., its previously announced merger partner (OTC:THER) (“Theralink”), and Theralink's Chairman, for the sale of its preferred stock and warrants. IMAC sold an aggregate of 2,500 shares of its Series A-1 Convertible Preferred Stock, stated value $1,000 per share, 1,800 shares of its Series A-2 Convertible Preferred Stock, stated value $1,000 per share, and Warrants to purchase up to 62,271,063 shares of its common stock for aggregate gross proceeds of $4,300,000 before deducting placement agent fees and other offering expenses. The shares of A-1 Convertible Preferred Stock, shall bear a 12% dividend, and are initially convertible into an aggregate of 22,893,773 shares of common stock of the Company, and the shares of Series A-2 Convertible Preferred Stock are initially convertible into an aggregate of 16,483,517 shares of common stock of the Company, in each case, at a conversion price of $0.1092 per share. The Warrants have an exercise price of $0.1092 per share, are exercisable immediately, and will expire five years from the date of shareholder approval of this private placement. It is expected that approximately $3.0 million of the proceeds of the offering will be used to make a loan to Theralink for investment into sales and marketing efforts and general working capital purposes as the companies continue to take formal steps together in advancing their merger previously announced on May 23, 2023. globenewswire.com - 1 year ago
Imac Holdings (IMAC) Receives a New Rating from Ascendiant Imac Holdings (IMAC) received a Buy rating from Ascendiant analyst Edward Woo today. The company's shares closed last Tuesday at $1.73. According to smarteranalyst.com - 4 years ago
8. Profile Summary

IMAC Holdings, Inc. BACK

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.76 M
Dividend Yield 0.00%
Description IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Contact 1605 Westgate Circle, Brentwood, TN, 37027 https://www.imacholdings.com
IPO Date Feb. 13, 2019
Employees 2
Officers Ms. Faith Zaslavsky Chief Executive Officer Ms. Sheri F. Gardzina CPA Chief Financial Officer & Corporate Secretary